Implementing a statin switching programme in primary care: Patients' views and experiences

British Journal of Clinical Pharmacology

Volumn 74, Issue 1, 2012, Pages 147-153

  Krska, Janet ^a   Allison, Katie ^a   Delargy, Michela ^a   Murray, Laura ^a   Smith, Hillary ^b  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b East Lancashire Primary Care Trust   (United Kingdom)

Author keywords

Drug switching; Patient opinion; Questionnaire; Statins

Indexed keywords

ATORVASTATIN; SIMVASTATIN;

ARTICLE; CLINICAL PRACTICE; DEMOGRAPHY; EDUCATIONAL STATUS; HEALTH PROGRAM; HUMAN; INTERVIEW; PHARMACIST; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; STATIN SWITCHING PROGRAM; TELECONSULTATION; TREATMENT RESPONSE; VALIDITY;

DRUG PRESCRIPTIONS; DRUG SUBSTITUTION; DRUGS, GENERIC; ENGLAND; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PATIENT COMPLIANCE; PHARMACISTS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; SOCIAL CLASS; THERAPEUTIC EQUIVALENCY;

EID: 84862146200     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2012.04183.x     Document Type: Article

References (18)

1. National Prescribing Centre. What you need to know about prescribing, the 'drugs bill' and medicines management: a guide for all NHS managers. 2008. Available at (last accessed 16 February 2012).
2. Garattini S, Bertele V, Godman B, Haycox A, Wettermark B, Gustafsson LL. Enhancing the rational use of new medicines across European healthcare systems: a position paper. Eur J Clin Pharmacol 2008; 64: 1137-8.
3. National Audit Office. Prescribing costs in primary care. 2007. Available at (last accessed 16 February 2012).
4. NHS Prescription Service. Drug tariff 2010. 2010. Available at (last accessed 16 February 2012).
5. Moon JC. Switching statins: using generic simvastatin as first line could save £2bn over five years in England. BMJ 2006; 332: 1344-5.
6. Institute for Innovation and Improvement. NHS better care, better value indicators. 2006. Available at (last accessed 16 February 2012).
7. National Prescribing Centre. Template for discussion points on statin switching. 2010. Available at (last accessed 16 February 2012).
8. Atar D, Carmena R, Clemmensen P, K-Laflamme A, Wassmann S, Lansberg P, Hobbs R. Clinical review: impact of statin substitution policies on patient outcomes. Ann Med 2009; 41: 242-56.
9. Duerden MG, Hughes DA. Generic and therapeutic substitutions in the UK: are they a good thing? Br J Clin Pharmacol 2010; 70: 335-41.
10. Usher-Smith JA, Ramsbottom T, Pearmain H, Kirby M. Evaluation of cost savings and clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a Primary Care setting. Int J Clin Pract 2007; 61: 15-23.
11. Thiebaud P, Patel B, Nichol M, Berenbein D. The effect of switching on compliance and persistence: the case of statin treatment. Am J Manag Care 2005; 11: 670-4.
12. Thompson A, Green S, Dubois S, Ansell A, Harewood E, Ayre J. Evaluation of patient satisfaction with switching medication. Prescriber 2006; 17: 27-35.
13. Harris International. Consumers' views on therapeutic substitution. 2008. Cited in: Johnston A. Challenges of therapeutic substitution of drugs for economic reasons: focus on CVD prevention. Current Med Res Opinion 2010; 26: 871-878.
14. Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen R-D, Kochen MM, Gleiter CH, Hummers-Pradier E. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther 2005; 43: 472-9.
15. Lambert Z, Doering P, Goldstein E, McCormick W. Predispositions toward generic drug acceptance. J Consum Res 1980; 7: 14-23.
16. Babar Z, Stewart J, Reddy S, Alzaher W, Vareed P, Yacoub N, Dhroptee B, Rew A. An evaluation of consumers' knowledge, perceptions and attitudes regarding generic medicines in Auckland. Pharm World Sci 2010; 32: 440-8.
17. Hassali MA, Shafie AA, Jamshed A, Ibrahim M, Awaisu A. Consumers' views on generic medicine: a review of literature. Int J Pharm Pract 2009; 17: 79-88.
18. Perreault S, Blais L, Lamarre D, Dragomir A, Berbiche D, Lalonde L, Laurier C, St-Maurice F, Collin J. Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention. Br J Clin Pharmacol 2005; 59: 564-73.